2022 BioMarin Golden Ticket

September 6, 2022

Share :

LabCentral 700

Applications Open for BioMarin-Sponsored LabCentral Golden Ticket, 2022!

As a Gold Sponsor of LabCentral, BioMarin Pharmaceutical Inc. is excited to expand their interactions with the Boston biotech community and support promising start-ups as they work to advance innovations towards new therapeutic options for patients.
The Golden Ticket provides the winning start-up with a $50,000 credit towards space at LabCentral 700, including the benefits of LabCentral’s shared infrastructure and services, to be used within 13 months of issue.

Focus Area
BioMarin is looking for start-ups developing innovative therapeutic approaches and enabling technologies that can correct molecular pathways that are altered in genetic diseases. Our standard boundary conditions are:

  • Genetic disease, with prevalence at least 1:50,000
  • Treatment addressing the underlying molecular pathology
  • Significant unmet clinical need with discernable clinical endpoints
  • Transformative impact - where treatment is expected to stop progression or provide reversal
  • Excluded therapeutic areas: oncology, infectious disease 

Technology Scope
We are interested in a broad range of modalities including:

  • Small Molecule and Biologic therapeutic approaches
  • Gene Therapy and Gene Editing
  • Oligonucleotide and mRNA directed therapies
  • Cell based therapies


  • Your start-up is working on innovation within BioMarin's focus area
  • Your start-up has raised less than $7.5M in equity financing
  • Your start-up does not have trailing 12-month revenues in excess of $3M
  • Your start-up will be able to utilize the value of the Golden Ticket towards space at LabCentral within 13 months of issue


  • Open call applications and application agreements accepted through 11:59pm PST 09/06/22
  • Finalists informed by 09/22/22
  • Finalists will be invited to present to BioMarin during a virtual pitch event on October 13th
  • Golden Ticket winner will be announced soon after the pitch event


Our Privacy Policy can be reviewed here:
Competition Terms and Conditions can be reviewed here: (PDF)
Application Agreement can be found here: